NX PharmaGen
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1827 S Bayshore Ln, Miami, Florida, 3313...Phone Number
(502) 741-5047Website
www.nxpharmagen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NX PharmaGen
NX PharmaGen is dedicated to advancing personalized medicine through next-generation molecular diagnostics and imaging technologies aimed at improving patient care. The company has developed several subsidiaries, including NX Development Corp., which focuses on imaging tools for brain tumor patients, and NX Prenatal Inc., which specializes in exosome-based diagnostics for maternal-fetal health. Additionally, Nexosome Oncology, a division of NX PharmaGen, is exploring exosome-based diagnostics in cancer to enhance treatment responsiveness. Their innovations are designed to benefit patients, physicians, and healthcare economics while expediting the approval of new medical interventions.Explore more
NX PharmaGen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NX PharmaGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if NX PharmaGen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at NX PharmaGen
Check out if NX PharmaGen is spiking on competitors!
Click to see if NX PharmaGen had a recent Job posting/layoffs
NX PharmaGen, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when NX PharmaGen launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once NX PharmaGen has new funding data
Earning: See what the market has to say on NX PharmaGen recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined NX PharmaGen as Masked Content
Find more new buyers
Compare Similar Companies to NX PharmaGen
Compare insights from companies similar to NX PharmaGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NX PharmaGen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NX PharmaGen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NX PharmaGen.
NX PharmaGen financials insights
Gather financial insights about NX PharmaGen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Private Equity
$773K
NX PharmaGen Tech Stack
A closer look at the technologies used by NX PharmaGen
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding NX PharmaGen
Sign Up For FreeTo access detailed company insights
NX PharmaGen is dedicated to advancing personalized medicine through next-generation molecular diagnostics and imaging technologies aimed at improving patient care. The company has developed several subsidiaries, including NX Development Corp., which focuses on imaging tools for brain tumor patients, and NX Prenatal Inc., which specializes in exoso... Read More
